By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


SIGA Technologies, Inc. 

420 Lexington Avenue
Suite 620
New York  New York  10170  U.S.A.
Phone: 212-672-9100 Fax: 212-697-3130



Gene Therapy

Company News
SIGA (SIGA) Announces Enrollment Of First Patients In The Final Cohort Of Phase III Study Of Tecovirimat 4/26/2016 12:36:12 PM
SIGA (SIGA) Successfully Emerges from Chapter 11 4/13/2016 6:01:00 AM
SIGA (SIGA) Commences Clinical Study For Intravenous (IV) Formulation Of TPOXX 3/17/2016 8:21:55 AM
FDA Concurs On Clinical Dose For SIGA (SIGA)’s Tecovirimat Antiviral 2/24/2016 11:25:19 AM
SIGA (SIGA) Announces That Delaware Supreme Court Affirms Court Of Chancery Opinion 12/28/2015 12:22:57 PM
SIGA (SIGA) Files Reorganization Plan to Exit from Bankruptcy 12/16/2015 6:21:03 AM
SIGA Technologies, Inc. (SIGA) Receives NASDAQ Delisting Notification 3/19/2015 12:45:36 PM
SIGA Technologies, Inc. (SIGA) Appeals Judgment Of Delaware Court Of Chancery 1/19/2015 11:25:05 AM
Court Orders SIGA Technologies, Inc. (SIGA) to Pay PharmAthene, Inc. (PIP) $113 Million 1/8/2015 6:03:46 AM
SIGA Technologies, Inc. (SIGA) Receives Bankruptcy Court Approval For First-Day Motions In Connection With Chapter 11 Case 9/18/2014 1:50:35 PM